Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|December 19, 2013
Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontinElla Fremder, Michal Munster, Anat Aharon, et al.
Cell Reports|April 27, 2017
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung MetastasesChen Rachman-Tzemah, Shelly Zaffryar-Eilot, Moran Grossman, et al.
Oncotarget|September 9, 2015
Dequalinium blocks macrophage-induced metastasis following local radiationMichael Timaner, Rotem Bril, Orit Kaidar-Person, et al.
Science (New York, N.Y.)|September 23, 2006
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumorsYuval Shaked, Alessia Ciarrocchi, Marcela Franco, et al.
Molecular Cancer Therapeutics|August 3, 2007
Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in miceUrban Emmenegger, Yuval Shaked, Shan Man, et al.
Cancer Research|November 7, 2019
Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor GrowthUdayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, et al.
Cell Death & Disease|December 18, 2024
Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localizationSoaad Soboh, Avital Vorontsova, Malik Farhoud, et al.
Journal for Immunotherapy of Cancer|June 18, 2021
IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cellsKsenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, et al.
Carcinogenesis|July 6, 2013
Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumoursShelly Zaffryar-Eilot, Derek Marshall, Tali Voloshin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growthFernando Doñate, Graham C Parry, Yuval Shaked, et al.
Pageof 14